Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Geoffrey Connors MD, FACP
Geoffrey R. Connors MD, FACP Associate Editor
Virginia Brady MD
Virginia A. Brady MD Associate Editor
Shyoko Honiden MD, MSc
Shyoko Honiden MD, MSc Editor-in-Chief
See All Experts
story of the week
Published in Respiratory Medicine

Journal Scan / Research · August 29, 2023

Low-Dose vs Conventional-Dose Trimethoprim–Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Patients Without HIV Infection

Chest

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Emmett Kistler MD

Emily McDonald MD, MSc

Chest
Low- Versus Conventional-Dose Trimethoprim-Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Non-Human Immunodeficiency Virus-Infected Patients: A Multi-Center, Retrospective Observational Cohort Study
Chest 2023 Aug 11;[EPub Ahead of Print], T Nagai, H Matsui, H Fujioka, Y Homma, A Otsuki, H Ito, S Ohmura, T Miyamoto, D Shichi, W Tomohisa, Y Otsuka, K Nakashima

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated